Related Experiment Video
Updated: Jun 6, 2026

08:37
Development of a Quantitative Recombinase Polymerase Amplification Assay with an Internal Positive Control
Published on: March 30, 2015
Evaluation of the Abbott ARCHITECT Chagas prototype assay.
Gerald Praast1, Jörg Herzogenrath, Stephanie Bernhardt
1Abbott GmbH & Co. KG, Wiesbaden-Delkenheim, Germany. gerald.praast@abbott.com
Diagnostic Microbiology and Infectious Disease
|December 15, 2010
Summary
New serologic tests improve Chagas disease diagnosis. The Abbott ARCHITECT Chagas assay shows superior sensitivity and specificity compared to existing enzyme-linked immunosorbent assays (ELISAs), offering reliable Trypanosoma cruzi infection detection.
Area of Science:
- Clinical diagnostics
- Parasitology
- Immunology
Background:
- Serologic tests are crucial for diagnosing Chagas disease and ensuring blood supply safety.
- Current enzyme-linked immunosorbent assays (ELISAs) often lack sufficient sensitivity and specificity for reliable Trypanosoma cruzi infection determination.
- Assay performance heavily depends on the selected antigens and their combination.
Purpose of the Study:
- To evaluate the performance of the Abbott ARCHITECT Chagas prototype assay.
- To compare the ARCHITECT assay against the bioMérieux ELISA cruzi assay for Chagas disease diagnosis.
Main Methods:
- Comparative performance analysis of two serologic assays for Chagas disease.
- Evaluation of specificity, sensitivity, and precision using key performance data.
Main Results:
- The Abbott ARCHITECT Chagas assay demonstrated higher specificity (99.99%) than the bioMérieux ELISA cruzi assay (99.93%).
- The ARCHITECT assay also showed superior sensitivity (99.85%) compared to the ELISA cruzi assay (98.38%).
- Excellent precision was observed with the ARCHITECT assay.
Conclusions:
- The Abbott ARCHITECT Chagas assay exhibits potential as a standalone diagnostic tool for Trypanosoma cruzi infection.
- Its high performance on an automated platform supports its use in blood screening and patient diagnosis.

